Jana Šímová

983 total citations
63 papers, 723 citations indexed

About

Jana Šímová is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Jana Šímová has authored 63 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Immunology, 21 papers in Genetics and 16 papers in Oncology. Recurrent topics in Jana Šímová's work include Immunotherapy and Immune Responses (37 papers), Virus-based gene therapy research (19 papers) and Immune Cell Function and Interaction (15 papers). Jana Šímová is often cited by papers focused on Immunotherapy and Immune Responses (37 papers), Virus-based gene therapy research (19 papers) and Immune Cell Function and Interaction (15 papers). Jana Šímová collaborates with scholars based in Czechia, Denmark and Sweden. Jana Šímová's co-authors include J Bubeník, M Indrová, T Jandlová, Jana Bieblová, Milan Reiniš, Romana Mikyšková, V. Vonka, Ivan Štěpánek, Luis Mendoza and Michal Šmahel and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and Journal of Leukocyte Biology.

In The Last Decade

Jana Šímová

62 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jana Šímová Czechia 15 533 269 231 109 108 63 723
M Indrová Czechia 16 588 1.1× 292 1.1× 281 1.2× 127 1.2× 103 1.0× 75 840
T Hamaoka Japan 10 755 1.4× 411 1.5× 171 0.7× 44 0.4× 78 0.7× 11 901
E Aruga United States 8 484 0.9× 283 1.1× 231 1.0× 31 0.3× 80 0.7× 9 646
R Brew United Kingdom 10 303 0.6× 224 0.8× 155 0.7× 35 0.3× 123 1.1× 16 579
György Stuber Sweden 14 468 0.9× 334 1.2× 149 0.6× 141 1.3× 30 0.3× 22 716
Ferdynand Kos United States 12 501 0.9× 241 0.9× 158 0.7× 227 2.1× 34 0.3× 15 725
Korina G. Veenstra United States 6 317 0.6× 216 0.8× 139 0.6× 40 0.4× 54 0.5× 8 484
Mara Valentini Italy 5 450 0.8× 379 1.4× 125 0.5× 44 0.4× 47 0.4× 5 643
Nourredine Himoudi United Kingdom 14 351 0.7× 292 1.1× 164 0.7× 58 0.5× 60 0.6× 18 599
Samuel Alsén Sweden 9 513 1.0× 277 1.0× 191 0.8× 43 0.4× 56 0.5× 15 737

Countries citing papers authored by Jana Šímová

Since Specialization
Citations

This map shows the geographic impact of Jana Šímová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana Šímová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana Šímová more than expected).

Fields of papers citing papers by Jana Šímová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jana Šímová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana Šímová. The network helps show where Jana Šímová may publish in the future.

Co-authorship network of co-authors of Jana Šímová

This figure shows the co-authorship network connecting the top 25 collaborators of Jana Šímová. A scholar is included among the top collaborators of Jana Šímová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jana Šímová. Jana Šímová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Šímová, Jana, et al.. (2013). Serum Levels of Matrix Metalloproteinases 2 and 9 and TGFBR2 Gene Screening in Patients with Ascending Aortic Dilatation. Folia Biologica. 59(4). 154–161. 5 indexed citations
3.
4.
Rosalia, Rodney Alexander, Ivan Štěpánek, Jana Šímová, et al.. (2012). Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model. Immunobiology. 218(6). 851–859. 7 indexed citations
5.
Šímová, Jana, M Indrová, Romana Mikyšková, et al.. (2011). Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status. British Journal of Cancer. 105(10). 1533–1541. 35 indexed citations
6.
Šímová, Jana, et al.. (2009). Therapy for minimal residual tumor disease: β‐Galactosylceramide inhibits the growth of recurrent HPV16‐associated neoplasms after surgery and chemotherapy. International Journal of Cancer. 126(12). 2997–3004. 9 indexed citations
7.
8.
Reiniš, Milan, et al.. (2005). Inhibitory effects of unmethylated CpG oligodeoxynucleotides on MHC class I‐deficient and ‐proficient HPV16‐associated tumours. International Journal of Cancer. 118(7). 1836–1842. 13 indexed citations
9.
Šímová, Jana, et al.. (2005). Immunotherapeutic Efficacy of Vaccines Generated by Fusion of Dendritic Cells and HPV16-Associated Tumour Cells. Folia Biologica. 51(1). 19–24. 6 indexed citations
10.
Šímová, Jana, et al.. (2004). The Role of NK1.1+ Cells in the Protection against MHC Class I+ HPV16-Associated Tumours. Folia Biologica. 50(6). 200–202. 7 indexed citations
11.
Mendoza, Luis, J Bubeník, Jana Šímová, et al.. (2003). Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours. International Journal of Oncology. 23(1). 243–7. 17 indexed citations
12.
Mendoza, Luis, J Bubeník, Jana Šímová, et al.. (2002). Tumour-Inhibitory Effects of Dendritic Cells Administered at the Site of HPV 16-Induced Neoplasms. Folia Biologica. 48(3). 114–119. 7 indexed citations
13.
Mendoza, Luis, J Bubeník, M Indrová, et al.. (2002). Freezing and Thawing of Murine Bone Marrow-Derived Dendritic Cells Does Not Alter Their Immunophenotype and Antigen Presentation Characteristics. Folia Biologica. 48(6). 242–245. 6 indexed citations
14.
Bubeník, J, et al.. (2000). Local cytokine treatment of HPV16-associated tumours results in inhibition of their lung metastases. Clinical & Experimental Metastasis. 18(7). 581–587. 7 indexed citations
15.
Bubeník, J, et al.. (2000). Intratumoral IL-2 Gene Transfer Improves the Therapeutic Efficacy of IL-12 but Not IL-18. Folia Biologica. 46(5). 191–193. 2 indexed citations
16.
17.
Indrová, M, et al.. (1996). Cross-reactivity of murine and hamster IL-2 mitogenic signal. Immunology Letters. 50(1-2). 115–117. 1 indexed citations
18.
Šímová, Jana, et al.. (1995). Interleukin-2 gene therapy of residual EL-4 leukaemia potentiates the effect of cyclophosphamide pretreatment. Journal of Cancer Research and Clinical Oncology. 121(1). 39–43. 7 indexed citations
19.
Šímová, Jana, et al.. (1993). Utilization of interleukin-2 gene transfer in local immunotherapy of cancer. Journal of Cancer Research and Clinical Oncology. 119(5). 253–256. 3 indexed citations
20.
Lotzová, Eva, et al.. (1992). Use of IL-2 gene transfer in local immunotherapy of cancer. Cancer Letters. 62(3). 257–262. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Indrová Breakdown of academic impact, for papers by T Hamaoka Breakdown of academic impact, for papers by E Aruga Breakdown of academic impact, for papers by R Brew Breakdown of academic impact, for papers by György Stuber Breakdown of academic impact, for papers by Ferdynand Kos Breakdown of academic impact, for papers by Korina G. Veenstra Breakdown of academic impact, for papers by Mara Valentini Breakdown of academic impact, for papers by Nourredine Himoudi Breakdown of academic impact, for papers by Samuel Alsén
Rankless by CCL
2026